Related Experiment Video
Updated: Jul 17, 2026

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
Statistical considerations for enumeration of circulating tumor cells.
Arjan G J Tibbe1, M Craig Miller, Leon W M M Terstappen
1Immunicon Corporation, Huntingdon Valley, Pennsylvania, USA.
Reducing errors in identifying circulating tumor cells (CTCs) could lower the threshold for poor prognosis in breast cancer patients from five to one CTC per 7.5 ml of blood. This improves patient stratification.
Area of Science:
- Oncology
- Biomedical Engineering
- Medical Statistics
Background:
- Circulating tumor cells (CTCs) are rare in carcinomas.
- In metastatic breast cancer, ≥5 CTCs/7.5ml blood correlates with poor survival.
- Understanding CTC detection limitations is crucial due to clinical implications.
Purpose of the Study:
- To develop a statistical model for CTC detection and enumeration.
- To identify sources of error in CTC analysis.
- To evaluate the impact of reducing errors on prognostic thresholds.
Main Methods:
- Statistical analysis of multi-center clinical trial data.
- Utilized the CellSearch® System for CTC isolation and enumeration.
- Modeled statistical issues from blood collection to image analysis.
Main Results:
- Developed a statistical model for CTC isolation and detection.
- Employed Poisson and empirical distributions for process steps.
- Reader variability identified as a key error source affecting the 5 CTC threshold.
Conclusions:
- Error reduction in CTC identification could lower the poor prognosis threshold.
- Potential to reduce threshold from 5 to 1 CTC/7.5ml blood.
- Improved patient stratification for metastatic breast cancer.
More Related Videos
05:17Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019